HBP is looking for Partners. The topic of this call is focused on novel molecular simulation based research efforts to accelerate the discovery of new and more effective treatments, based on allosteric mechanisms, reducing the problem of side effects, whilst speeding up and drastically lowering the cost of drug discovery. The winning proposal will become part of the envisioned overall HBP Work Plan for the second Specific Grant Agreement (SGA2; 1 April 2018 to 31 March 2020) as new Tasks.
Eligibility: Organisations, either already part of the HBP Consortium or not.
Funding: EUR 250,000 (EU contribution including 25% indirect costs, H2020 rules), for one proposal with two partners.